Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
SuRE Award funds biomedical research at universities without current NIH grants, promoting research capacity building and enhancing student research experiences.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates: May 28, 2025 | September 7, 2025 (AIDS) | September 29, 2025 | January 7, 2026 (AIDS) | May 27, 2026 | September 7, 2026 (AIDS) | September 28, 2026 | January 7, 2027 (AIDS)
Funding Amounts: Up to $100,000 direct costs per year for up to 4 years; excludes consortium F&A costs.
Summary: Supports investigator-initiated biomedical research at resource-limited higher education institutions to build research capacity and provide high-quality research experiences for students.
Key Information: Clinical trials are not allowed; limited to institutions with low NIH RPG funding and specific eligibility criteria.
Description
The Support for Research Excellence (SuRE) Award (R16) is a National Institutes of Health (NIH) program designed to enhance research capacity at resource-limited higher education institutions. The program funds investigator-initiated biomedical research in basic, social, clinical, behavioral, or translational science that aligns with the mission areas of the NIH. SuRE awards aim to:
- Support faculty investigators at institutions with limited NIH Research Project Grant (RPG) funding who are not currently funded by any NIH RPG (except SuRE or SuRE-First awards).
- Provide students with high-quality undergraduate and/or graduate research experiences.
- Strengthen the scientific research culture and infrastructure at eligible institutions.
Projects must include significant student participation in research execution, analysis, and reporting. The program is not open to clinical trials.
